Statins in rheumatology
Keywords:
atherosclerosis, statins, rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, goutAbstract
Application of inhibitors of HMG-CoA reductase in patients with rheumatologic diseases is currently limited by
hypercholesterolemia. The presence of rheumatic diseases in a patient does not included in current algorithms for
assessing cardiovascular risk. This review provides information about additional factors of cardiovascular risk in
patients with various rheumatologic diseases
Downloads
Download data is not yet available.
Downloads
Published
2011-06-29
How to Cite
Tutunov V. S., Zubarev M. Y., Malyshev P. P., Kukharchuk V. V. Statins in rheumatology // The Journal of Atherosclerosis and Dyslipidemias. 2011. VOL. № 2 (3). PP. 43–48.
Issue
Section
Review